Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.55M Buy
+79,400
New +$9.17M 0.02% 639
2025
Q4
Sell
-127,500
Closed -$10.7M 3710
2025
Q3
$10.7M Buy
127,500
+100,600
+374% +$8.29M 0.04% 375
2025
Q2
$2.13M Buy
+26,900
New +$2.14M 0.01% 897
2025
Q1
Sell
-20,900
Closed -$2.08M 3073
2024
Q4
$2.08M Buy
+20,900
New +$2.15M 0.01% 725
2024
Q3
Sell
-10,600
Closed -$1.31M 2863
2024
Q2
$1.31M Buy
+10,600
New +$1.37M 0.01% 895
2022
Q1
Sell
-9,900
Closed -$758K 3574
2021
Q4
$758K Buy
+9,900
New +$789K ﹤0.01% 1367

Other funds holding MRK

HRT Financial's MRK Position: Q1 2026 in Review

HRT Financial reduced its Merck (MRK) stake by 77% in Q1 2026, selling an estimated $54.3M and leaving 142,729 shares worth $17.2M. The position accounts for 0.04% of the portfolio, ranked #396.

HRT Financial first reported a position in MRK in Q4 2014 and has held it in 20 quarters since. The position peaked at $208M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • HRT Financial held 142,729 shares of Merck worth $17.2M as of Q1 2026.
  • HRT Financial sold 470,027 Merck shares in Q1 2026, an estimated $54.3M.
  • Merck made up 0.04% of HRT Financial's portfolio in Q1 2026, its #396 holding.
  • HRT Financial first reported a position in Merck in Q4 2014 and has held it in 20 quarters since.
  • HRT Financial's Merck position peaked at $208M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.